Remdesivir News and Research

RSS
A traditional Chinese medicine could help treat COVID‐19 symptoms

A traditional Chinese medicine could help treat COVID‐19 symptoms

Carbon-based nanomaterials as potential COVID-19 treatments

Carbon-based nanomaterials as potential COVID-19 treatments

Prolonged shedding and multiple mutations 154 days after initial SARS-CoV-2 diagnosis reported

Prolonged shedding and multiple mutations 154 days after initial SARS-CoV-2 diagnosis reported

Combination therapy reduces recovery time in COVID-19 patients, clinical trial finds

Combination therapy reduces recovery time in COVID-19 patients, clinical trial finds

Study reports promising new monoclonal antibody against SARS-CoV-2’s spike protein

Study reports promising new monoclonal antibody against SARS-CoV-2’s spike protein

Influenza drug enisamium a potential COVID-19 treatment

Influenza drug enisamium a potential COVID-19 treatment

Could fenofibrate be an effective antiviral against SARS-CoV-2?

Could fenofibrate be an effective antiviral against SARS-CoV-2?

Scientists identify sensor in human lungs that detects SARS-CoV-2

Scientists identify sensor in human lungs that detects SARS-CoV-2

Could Ivermectin be an effective antiviral against SARS-CoV-2?

Could Ivermectin be an effective antiviral against SARS-CoV-2?

Potential role of chitinase 3-like-1 in severity of COVID-19

Potential role of chitinase 3-like-1 in severity of COVID-19

Disulfide-reducing agents demonstrate potential antiviral activity against SARS-CoV-2

Disulfide-reducing agents demonstrate potential antiviral activity against SARS-CoV-2

Researchers identify natural products with potential to disrupt viral spread

Researchers identify natural products with potential to disrupt viral spread

Glycyrrhizin in licorice root neutralizes SARS-CoV-2 in vitro by inhibiting the main protease Mpro

Glycyrrhizin in licorice root neutralizes SARS-CoV-2 in vitro by inhibiting the main protease Mpro

Covid ‘decimated our staff’ as the pandemic ravages health workers of color in US

Covid ‘decimated our staff’ as the pandemic ravages health workers of color in US

FDA-approved COVID-19 drug should be used cautiously, says UC researcher

FDA-approved COVID-19 drug should be used cautiously, says UC researcher

UMSOM researchers find greatest risk factors for death in hospitalized COVID-19 patients

UMSOM researchers find greatest risk factors for death in hospitalized COVID-19 patients

Remdesivir inhibits SARS-CoV-2 replication by preventing RdRp-mediated RNA translocation

Remdesivir inhibits SARS-CoV-2 replication by preventing RdRp-mediated RNA translocation

Hepatitis C virus drugs synergize with remdesivir against SARS-CoV-2 in vitro

Hepatitis C virus drugs synergize with remdesivir against SARS-CoV-2 in vitro

Research reveals two phases of infection in patients with severe COVID-19 pneumonia

Research reveals two phases of infection in patients with severe COVID-19 pneumonia

Azithromycin trial fails to provide evidence of benefit in COVID-19

Azithromycin trial fails to provide evidence of benefit in COVID-19